Pharmaceutical R&D: Costs, Risks, and Rewards (1993)

Chapter: APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data

Previous Chapter: APPENDIX C: The Cost of Capital
Suggested Citation: "APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 284
Suggested Citation: "APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 285
Suggested Citation: "APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 286
Suggested Citation: "APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 287
Suggested Citation: "APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 288
Suggested Citation: "APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 289
Next Chapter: APPENDIX E: Patent Protection of Pharmaceuticals in the United States
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.